Immunohistochemical evaluation of ProEx C in human papillomavirus-induced lesions of the cervix

Journal of Clinical Pathology

Volumn 62, Issue 2, 2009, Pages 159-162

  Conesa Zamora, P ^a   Domenech Peris A ^a   Ortiz Reina, S ^a   Orantes Casado, F J ^a   Acosta Ortega, J ^a   Garcia Solano J ^a   Perez Guillermo M ^a  

^a Hospital Universitario Santa Maria del Rosell   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; PROEX C; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE MICROARRAY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOENZYME TECHNIQUES; INDICATORS AND REAGENTS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 61449145548     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.061408     Document Type: Article

References (17)

1. Muñoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
2. Chen Y, Miller C, Mosher R, et al. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res 2003;63:1927-35.
3. Santin AD, Zhan F, Bignotti E, et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005;331:269- 91.
4. Romanowski P, Madine MA. Mechanisms restricting DNA replication to once per cell cycle: the role of Cdc6p and ORC. Trends Cell Biol 1997;7:9-10.
5. Kelly D, Kincaid E, Fansler Z, et al. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C). Cancer 2006;108:494-500.
6. Shroyer KR, Homer P, Heinz D, et al. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein2 expression in cervical cytology. Cancer 2006;108:324-30.
7. Shi J, Liu H, Wilkerson M, et al. Evaluation of p16INK4a, minichromosomemaintenance protein 2, DNA topoisomerase Ilalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. Hum Pathol 2007;38:1335-44.
8. Badr RE, Walts AE, Chung F, et al. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol 2008;32:899-906.
9. Pinto AP, Schlecht NF, Woo YCT, et al. Biomarker (ProEx(TM) C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Mod Pathol 2008;21:1067-74.
10. Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 1999;5:2121-32.
11. Schneider V. Tissue microarrays for testing molecular biomarkers of cervical intraepithelial neoplasia: feasibility study. Acta Cytol 2006;50:121-2.
12. Tawfik El-Mansi M, Williams AR. Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system. Int J Gynecol Cancer 2006;16:1225-33.
13. Alkushi A, Irving J, Hsu F, et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 2003;442:271-7.
14. Nijhuis ER, Nijman HW, Oien KA, et al. Loss of MSH2 protein expression is a risk factor in early stage cervical cancer. J Clin Pathol 2007;60:824-30.
15. Zhang Z, Huettner PC, Nguyen L, et al. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. Oncogene 2006;25:5436-15.
16. Feng W, Xiao J, Zhang Z, et al. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma. Mod Pathol 2007;20:961-6.
17. Nam EJ, Kim JW, Kim SW, et al. The expressions of the Rb pathway in cervical intraepithelial neoplasia: predictive and prognostic significance. Gynecol Oncol 2007;104:207-11.